Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enoxaparin dosing strategy for venous thromboembolism prevention in critically ill patients with acute kidney injury on CRRT
2012-004368-23Phase 4Terminated
- Sponsor
- University Hospital Odense
- Start
- Oct 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of enoxaparin in venous thromboembolism (VTE), sponsored by University Hospital Odense. Started Oct 2012; status: terminated.
02
Drugs
enoxaparin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on 2012-004368-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-004368-23.